Medical Care Germany · Berlin
Structured access to oncological expertise at German university hospitals for complex cases requiring multidisciplinary evaluation.
Overview
Germany's university medical centers operate comprehensive oncology departments where specialists across surgical oncology, medical oncology, radiation oncology, and pathology collaborate within structured tumor boards. International patients with complex or advanced cancer diagnoses may access this framework through coordinated clinical pathway management, ensuring that treatment decisions are supported by the full depth of German academic medicine.
Cancer Types
Each cancer type requires a distinct diagnostic and treatment approach. The following pages provide detailed information on specialist access and treatment options in Germany for specific oncological conditions.
Oncology
Multidisciplinary breast oncology including molecular subtyping, surgical options, and targeted therapy access at German university centers.
View details →Oncology
NSCLC and SCLC treatment including molecular profiling (EGFR/ALK/ROS1/KRAS/PD-L1), VATS, robotic lobectomy, and SBRT.
View details →Oncology
Robotic surgery, PSMA PET-CT staging, Lu-177 radioligand therapy, and focal treatment options at specialist German centers.
View details →About Cancer
Cancer encompasses a broad range of malignant conditions affecting different organ systems, each requiring individualized diagnostic workup, staging, and treatment planning. Accurate molecular profiling, imaging interpretation, and pathological classification are foundational to determining the appropriate therapeutic strategy. Complex cases — including rare tumors, recurrent disease, or cases where prior treatment has not achieved the desired response — often benefit from specialist re-evaluation within a multidisciplinary setting.
Why Germany
German university hospitals are equipped with advanced diagnostic infrastructure including PET-CT, molecular pathology laboratories, and interventional radiology capabilities. Tumor boards convene regularly to review individual cases, ensuring that treatment recommendations reflect current evidence and the combined expertise of multiple specialists. Germany's healthcare framework supports structured access to clinical trials, targeted therapies, and immunotherapy protocols for eligible patients.
Specialist Evaluation
A specialist evaluation begins with a structured review of available documentation, including pathology reports, imaging studies, and prior treatment records. German oncologists assess the completeness of the diagnostic workup, identify whether additional staging or molecular testing is indicated, and determine which treatment modalities — surgical, systemic, radiotherapeutic, or combined — are appropriate for the individual clinical situation.
FAQ
Related